Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 5 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar javnnf (26.51) Submitted: 8/17/2007 6:57:03 PM : Outperform Start Price: $12.42 FLML Score: -60.53

badly beaten up!

Featured Broker Partners


Advertisement